Smith & Nephew SNATS Other Operating Income or Expenses 2010-2024 | SNN

Smith & Nephew SNATS annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Smith & Nephew SNATS other operating income or expenses for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS other operating income or expenses for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS annual other operating income or expenses for 2024 were $0B, a 0% decline from 2023.
  • Smith & Nephew SNATS annual other operating income or expenses for 2023 were $0B, a 0% decline from 2022.
  • Smith & Nephew SNATS annual other operating income or expenses for 2022 were $0B, a 0% decline from 2021.
Smith & Nephew SNATS Annual Other Operating Income or Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Smith & Nephew SNATS Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.272B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.763B 27.35
Boston Scientific (BSX) United States $152.152B 38.10
Stryker (SYK) United States $142.721B 30.67
EssilorLuxottica (ESLOY) France $133.556B 0.00
Medtronic (MDT) Ireland $108.708B 15.87
Lonza Group Ag (LZAGY) Switzerland $51.613B 0.00
Haleon (HLN) United Kingdom $45.796B 26.03
ResMed (RMD) United States $34.691B 26.06
GE HealthCare Technologies (GEHC) United States $32.200B 15.29
Agilent Technologies (A) United States $30.677B 20.26
Terumo (TRUMY) Japan $28.397B 0.00
Koninklijke Philips (PHG) Netherlands $23.827B 17.01
Zimmer Biomet Holdings (ZBH) United States $20.388B 12.88
Insulet (PODD) United States $17.717B 75.76
Baxter (BAX) United States $15.988B 11.50
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.145B 17.57
Bio-Rad Laboratories (BIO) United States $6.837B 23.67
Prestige Consumer Healthcare (PBH) United States $4.024B 19.20
Perrigo (PRGO) Ireland $3.510B 10.05
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.362B 28.64
Haemonetics (HAE) United States $3.166B 14.90
Envista Holdings (NVST) United States $2.725B 22.03
GN Store Nord (GNNDY) Denmark $2.260B 18.72
LeMaitre Vascular (LMAT) United States $2.050B 46.77
QuidelOrtho (QDEL) United States $1.875B 15.70
AtriCure (ATRC) United States $1.480B 0.00
Green Thumb Industries (GTBIF) United States $1.401B 22.00
Kestra Medical Technologies (KMTS) United States $1.235B 0.00
AdaptHealth (AHCO) United States $1.148B 11.05
BioLife Solutions (BLFS) United States $1.145B 0.00
Neogen (NEOG) United States $1.096B 14.03
InMode (INMD) Israel $0.981B 8.98
Phibro Animal Health (PAHC) United States $0.754B 11.56
Evolus (EOLS) United States $0.735B 0.00
Curaleaf Holdings (CURLF) Canada $0.713B 0.00
Capricor Therapeutics (CAPR) United States $0.580B 0.00
CeriBell (CBLL) United States $0.577B 0.00
Owens & Minor (OMI) United States $0.545B 4.64
Valneva SE (VALN) France $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.514B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Cresco Labs (CRLBF) United States $0.479B 0.00
Omeros (OMER) United States $0.427B 0.00
Surmodics (SRDX) United States $0.400B 0.00
SNDL (SNDL) Canada $0.392B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.343B 14.86
Verano Holdings (VRNOF) United States $0.323B 0.00
Sanara MedTech (SMTI) United States $0.284B 0.00
Viemed Healthcare (VMD) United States $0.279B 25.25
Aurora Cannabis (ACB) Canada $0.261B 46.40
Canopy Growth (CGC) Canada $0.254B 0.00
Cerus (CERS) United States $0.252B 0.00
ZimVie (ZIMV) United States $0.252B 15.10
OraSure Technologies (OSUR) United States $0.232B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
Quanterix (QTRX) United States $0.223B 0.00
High Tide (HITI) Canada $0.195B 0.00
Biote (BTMD) United States $0.182B 4.16
Utah Medical Products (UTMD) United States $0.170B 13.69
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
Brainsway (BWAY) Israel $0.164B 51.00
Organigram Global (OGI) Canada $0.146B 0.00
Jin Medical (ZJYL) China $0.142B 0.00
FitLife Brands (FTLF) United States $0.142B 17.46
TerrAscend (TSNDF) Canada $0.128B 0.00
Agape ATP (ATPC) $0.115B 0.00
Exagen (XGN) United States $0.112B 0.00
MacroGenics (MGNX) United States $0.109B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.082B 0.00
Veru (VERU) United States $0.079B 0.00
Fonar (FONR) United States $0.078B 10.91
InterCure (INCR) Israel $0.072B 0.00
United Health Products (UEEC) United States $0.065B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Zynex (ZYXI) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Apyx Medical (APYX) United States $0.039B 0.00
Safety Shot (SHOT) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.037B 54.00
United-Guardian (UG) United States $0.036B 11.14
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00